HOME >> BIOLOGY >> NEWS
Genetic discovery in fruit flies may open new avenues for understanding cancer growth in humans

appropriate gene silencing is thought to account for various sex-linked genetic disorders, in which the affected genes are located on the X chromosome. Such developmental abnormalities, which nearly always affect males, include xeroderma pigmentosum (a rare, inherited skin disease that causes extreme sensitivity to sunlight and increased risk of skin cancer), color blindness and hemophilia.

Malfunctions in gene silencing also have been implicated in several human cancers, including acute myelogenous leukemia, colon cancer and several forms of breast cancer.

Sir2 is an attractive drug target because it has been found to modulate the function of p53, an important tumor-suppressor protein which, when defective, can increase cancer risk in humans. One drug under investigation at Fred Hutchinson, called Splitomicin, is a potent inhibitor of gene silencing. It works by interfering with Sir2's ability to cloak the chromosome in proteins that shield it from factors needed for activation. The compound is highly specific, halting the function of Sir2. Such precision is an attractive feature in drug design because it increases a drug's effectiveness and decreases its side effects. Fred Hutchinson researchers scientifically reported the drug's discovery last December and the center has filed patent protection for it.

In the Cell paper, Parkhurst and Rosenberg report that the drug, which already has been shown to reverse global gene silencing in yeast, also works in fruit flies.

"With fruit flies, we now have a multi-cellular model system that is more complex than yeast that will allow us to study all of the functional components of the pathway that are required for the drug to work," Parkhurst said. "Now that we know the drug works on fruit fly Sir2, this opens up all kinds of possibilities that we wouldn't have thought to try before." For example, this finding now hints at the drug's potential for treating diseases that result from the faulty regulation
'"/>

Contact: Kristen Woodward
kwoodwar@fhcrc.org
206-667-5095
Fred Hutchinson Cancer Research Center
16-May-2002


Page: 1 2 3 4

Related biology news :

1. Genetic mutations linked to the practice of burning coal in homes in China
2. Genetic differences might help distinguish thyroid cancers
3. Genetic modification of linseed produces healthier omega 3 and 6 fatty acids
4. Wiley publishes Welcome to the Genome: A Users Guide to the Genetic Past, Present, and Future
5. Genetically modified bacterium as remedy for intestinal diseases
6. Genetic analysis rewrites salamanders evolutionary history
7. Genetic map of important tree genes outlined
8. Genetically-engineered marathon mouse keeps on running
9. Genetic clues found for common congenital brain disorder
10. Genetic mutation linked to more aggressive breast cancer found more often in African-Americans
11. Genetic discovery could dramatically reduce need for liver transplants in children

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/29/2019)... ... March 29, 2019 , ... GenCure has selected ... cell therapy facility. The new facility, which will anchor the VelocityTX innovation center ... the art manufacturing capabilities to support clinical cell therapy trials. GenCure is a ...
(Date:3/25/2019)... ... March 25, 2019 , ... Ambry Genetics ... genetic testing, today announced a new laboratory services agreement with Clovis Oncology Inc., ... Through this laboratory services agreement, Ambry Genetics and Clovis Oncology seek to ...
(Date:3/19/2019)... , ... March 19, 2019 , ... ... EMulate Therapeutics, Inc. The name change is effective immediately for the ... other serious diseases. , In making the announcement, Chris Rivera, Chief Executive ...
Breaking Biology News(10 mins):
(Date:4/9/2019)... ... 09, 2019 , ... The American Society of Gene & Cell Therapy ... including a new addition to the presidential line of succession, at the 22nd ... Society's leadership team for a three-year term (2019-2021). , All five incoming members of ...
(Date:4/8/2019)... (PRWEB) , ... April 09, 2019 , ... ... disease, the innovative non-profit research center Chan Zuckerberg Biohub (CZ Biohub) has chosen ... of antibody repertoires is part of CZ Biohub’s efforts to establish new approaches ...
(Date:3/29/2019)... ... March 28, 2019 , ... Specific Diagnostics announced ... proceeded with a second stage of funding for Specific’s Reveal™ rapid antibiotic susceptibility ... top of the $1.7 million already awarded by CARB-X. The additional $1.7M will ...
(Date:3/27/2019)... ... 27, 2019 , ... Lachman is sponsoring the event on April 1-4, where ... Ireland. The executive team on site will be available to discuss strategies and tactics ... agenda this year. , Executives from Lachman participating at this year’s conference include Fran ...
Breaking Biology Technology:
Cached News: